BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11789553)

  • 1. Assessing the reliability of the EORTC QLQ-C30 in a sample of older African American and Caucasian adults.
    Ford ME; Havstad SL; Kart CS
    Qual Life Res; 2001; 10(6):533-41. PubMed ID: 11789553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
    Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
    J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30.
    Lundy JJ; Coons SJ; Aaronson NK
    Patient; 2015 Apr; 8(2):165-70. PubMed ID: 24958466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].
    Zawisza K; Tobiasz-Adamczyk B; Nowak W; Kulig J; Jedrys J
    Ginekol Pol; 2010 Apr; 81(4):262-7. PubMed ID: 20476597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore.
    Luo N; Fones CS; Lim SE; Xie F; Thumboo J; Li SC
    Qual Life Res; 2005 May; 14(4):1181-6. PubMed ID: 16041912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Korean version of the EORTC QLQ-C30.
    Yun YH; Park YS; Lee ES; Bang SM; Heo DS; Park SY; You CH; West K
    Qual Life Res; 2004 May; 13(4):863-8. PubMed ID: 15129896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status.
    Paiva CE; Carneseca EC; Barroso EM; de Camargos MG; Alfano AC; Rugno FC; Paiva BS
    Support Care Cancer; 2014 Aug; 22(8):2151-60. PubMed ID: 24652051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
    Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
    Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of EORTC QLQ-C30 and PRO-CTCAE™ Questionnaires on Six Symptom Items.
    Taarnhøj GA; Kennedy FR; Absolom KL; Bæksted C; Vogelius IR; Johansen C; Velikova G; Pappot H
    J Pain Symptom Manage; 2018 Sep; 56(3):421-429. PubMed ID: 29807157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.
    Shen MH; Chen LP; Ho TF; Shih YY; Huang CS; Chie WC; Huang CC
    BMC Cancer; 2018 Apr; 18(1):353. PubMed ID: 29606101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.
    Kecke S; Ernst J; Einenkel J; Singer S; Hinz A
    J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.